Advisory Services Network, LLC Purple Biotech Ltd. Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.78 - $1.67 $1,556 - $3,331	1,995 New	1,995 $1,000
Q4 2022 Feb 13, 2023	BUY	$1.38 - $2.22 $2,753 - $4,428	1,995 New	1,995 $2,000
Q3 2021 Nov 05, 2021	SELL	$4.4 - $5.59 $8,558 - $10,872	-1,945 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.75 - $6.72 $7,293 - $13,070	1,945 New	1,945 $9,000
Q1 2021 May 24, 2021	SELL	$3.93 - $6.99 $7,643 - $13,595	-1,945 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$3.81 - $4.73 $7,410 - $9,199	1,945 New	1,945 $7,000

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $67M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.